loader

World Tenders & Procurement Opportunities

Endocrine therapy medicinal products - Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02)

World Biggest Tenders Source

This tender with title Endocrine therapy medicinal products - Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02) has been published on Bidding Source portal dated 14 Apr 2020 for the country of Germany. It has been categorized on Endocrine therapy medicinal products. For similar tenders you can see tenders mentioned below of this page.

General Information

Endocrine therapy medicinal products - Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02)
Invitation for Bids
2020/S 072-170749
Germany
Germany-Hanover
14 Apr 2020
27 Mar 2022
English
Endocrine therapy medicinal products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Germany - Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient fulvestrant (ATC code: L02BA03). -- <br><b>Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03).</b> Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02) -- Endocrine therapy medicinal products Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03) Germany Germany-Hanover: Endocrine therapy medicinal products Germany 554980-Awarded - Portugal – Endocrine therapy medicinal products – 2024/0780 - OCTREOTIDO [20 MG/ 2 ML; IM; F/AMP] Portugal 556869-Awarded - Portugal – Endocrine therapy medicinal products – 2024/0780 - OCTREOTIDO [20 MG/ 2 ML; IM; F/AMP] Portugal 557075-Awarded - Portugal – Endocrine therapy medicinal products – 2024/0780 - OCTREOTIDO [20 MG/ 2 ML; IM; F/AMP] Portugal 547519-Awarded - Cyprus – Endocrine therapy medicinal products – Tender for the supply of Fulvestrant 250mg/5ml solution for injection - no. diag. 81/2025 (OAY) -- <b>Contract Value: 198 450,00 EUR</b> Cyprus PROCUREMENT OF DRUGS USED IN MANAGEMENT OF ENDOCRINE DISORDERS (ANNUAL REQUIREMENT) HEALTH/IFB/2025/2288 - 6999133 Mauritius Tender for the Supply of Leuprorelin Acetate 3.75mg Suspension for Injection - 8334649 Malta
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans